13D/13G Filings - ReShape Lifesciences Inc. (RSLS)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-12
06:09 am
Unchanged
2010-02-28 13G ReShape Lifesciences Inc.
RSLS
INTERWEST PARTNERS X LP 46
5.100%
0
(Unchanged)
Filing
History
2021-01-08
09:49 am
Sale
2020-12-31 13G ReShape Lifesciences Inc.
RSLS
SABBY MANAGEMENT LLC 45
11.000%
-21decrease
(-32.02%)
Filing
History
2020-11-10
5:14 pm
Purchase
2020-10-31 13G ReShape Lifesciences Inc.
RSLS
Armistice Capital, LLC 126
14.200%
46increase
(+57.21%)
Filing
History
2020-10-23
4:30 pm
Unchanged
2020-10-23 13D ReShape Lifesciences Inc.
RSLS
DOMAIN PARTERS VII L P 115
12.600%
0
(Unchanged)
Filing
History
2020-09-25
4:33 pm
Purchase
2020-09-17 13G ReShape Lifesciences Inc.
RSLS
Armistice Capital, LLC 80
9.000%
80increase
(New Position)
Filing
History
2020-08-31
4:26 pm
Purchase
2020-08-24 13G ReShape Lifesciences Inc.
RSLS
MORGAN STANLEY
MS
52
5.900%
52increase
(New Position)
Filing
History
Goto Prev, 0, 1